Clinicians, AIDS Activists Urge CMS Coverage Of Facial Wasting Treatments
This article was originally published in The Gray Sheet
Executive Summary
Dermatologists, HIV clinicians and an AIDS activist group are urging CMS to cover reconstructive treatments for facial lipodystrophy syndrome, a disfiguring side effect of human immunodeficiency virus medications